Stocks Overview

LAST PRICE
34.0700
TODAY'S CHANGE (%)
Trending Up0.8400 (2.5278%)

Bid / Lots
32.1000/ 1
Ask / Lots
35.4800/ 2
Open / Previous Close
33.1700 / 33.2300
Day Range
Low 32.9000
High 34.1700
52 Week Range
Low 27.9700
High 41.6100
Volume
517,891
average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Thursday's close: 33.23
Time	Volume	HRMY
09:32 ET	3473	33.17
09:33 ET	300	33.325
09:35 ET	100	33.11
09:37 ET	400	33.145
09:39 ET	200	33.255
09:42 ET	300	33.1
09:44 ET	300	33.35
09:46 ET	500	33.35
09:48 ET	200	33.46
09:51 ET	300	33.49
09:53 ET	795	33.735
10:00 ET	400	33.515
10:02 ET	146	33.76
10:04 ET	147	33.565
10:09 ET	1220	33.59
10:11 ET	100	33.585
10:13 ET	300	33.51
10:18 ET	262	33.615
10:22 ET	900	33.61
10:24 ET	400	33.43
10:26 ET	100	33.485
10:27 ET	175	33.505
10:29 ET	701	33.45
10:31 ET	300	33.495
10:33 ET	1105	33.505
10:36 ET	292	33.495
10:38 ET	200	33.55
10:42 ET	2800	33.65
10:44 ET	3100	33.55
10:45 ET	31523	33.54
10:47 ET	600	33.51
10:51 ET	300	33.4995
10:54 ET	1715	33.5012
10:56 ET	100	33.4732
10:58 ET	100	33.48
11:00 ET	200	33.48
11:02 ET	207	33.525
11:03 ET	100	33.535
11:07 ET	537	33.525
11:09 ET	638	33.525
11:12 ET	200	33.58
11:14 ET	600	33.575
11:16 ET	300	33.52
11:21 ET	100	33.64
11:25 ET	400	33.64
11:27 ET	3858	33.6
11:30 ET	1808	33.615
11:32 ET	300	33.62
11:34 ET	300	33.6057
11:36 ET	100	33.62
11:38 ET	3675	33.65
11:39 ET	203	33.65
11:41 ET	100	33.68
11:43 ET	300	33.66
11:45 ET	100	33.64
11:48 ET	100	33.66
11:50 ET	2200	33.63
11:52 ET	100	33.635
11:54 ET	100	33.635
11:56 ET	100	33.64
11:57 ET	200	33.65
11:59 ET	800	33.63
12:06 ET	1600	33.6202
12:08 ET	200	33.62
12:12 ET	200	33.65
12:14 ET	300	33.63
12:15 ET	400	33.6
12:17 ET	1300	33.61
12:19 ET	100	33.59
12:21 ET	200	33.6
12:26 ET	200	33.61
12:28 ET	1008	33.58
12:30 ET	1500	33.49
12:32 ET	500	33.44
12:33 ET	300	33.365
12:35 ET	100	33.41
12:37 ET	100	33.415
12:50 ET	1600	33.46
12:53 ET	400	33.53
12:55 ET	1661	33.47
01:00 ET	100	33.45
01:04 ET	200	33.485
01:06 ET	1300	33.38
01:11 ET	300	33.4
01:13 ET	100	33.39
01:15 ET	100	33.4028
01:18 ET	300	33.38
01:27 ET	100	33.43
01:29 ET	1100	33.355
01:31 ET	300	33.39
01:38 ET	583	33.44
01:42 ET	200	33.38
01:44 ET	2439	33.435
01:45 ET	1200	33.435
01:49 ET	5602	33.465
01:51 ET	100	33.485
01:54 ET	300	33.49
01:56 ET	100	33.49
01:58 ET	1100	33.525
02:02 ET	620	33.51
02:03 ET	200	33.57
02:05 ET	1916	33.57
02:07 ET	600	33.61
02:09 ET	10971	33.58
02:12 ET	25300	33.64
02:14 ET	100	33.655
02:16 ET	250	33.7
02:18 ET	200	33.74
02:20 ET	400	33.74
02:21 ET	633	33.8
02:23 ET	100	33.82
02:25 ET	1200	33.805
02:27 ET	400	33.77
02:30 ET	200	33.795
02:32 ET	700	33.87
02:34 ET	632	33.835
02:36 ET	2500	33.8
02:38 ET	100	33.895
02:43 ET	700	33.86
02:45 ET	100	33.89
02:48 ET	1666	33.86
02:50 ET	800	33.86
02:52 ET	709	33.84
02:54 ET	1200	33.83
02:57 ET	1968	33.81
02:59 ET	675	33.77
03:03 ET	742	33.745
03:06 ET	848	33.74
03:08 ET	700	33.74
03:10 ET	400	33.72
03:12 ET	100	33.74
03:14 ET	1300	33.635
03:15 ET	100	33.67
03:17 ET	800	33.71
03:19 ET	600	33.7
03:21 ET	1647	33.67
03:24 ET	100	33.66
03:26 ET	520	33.68
03:28 ET	100	33.6733
03:30 ET	200	33.6606
03:32 ET	3340	33.675
03:33 ET	500	33.69
03:35 ET	200	33.69
03:37 ET	6470	33.755
03:39 ET	311	33.76
03:42 ET	2400	33.75
03:44 ET	100	33.75
03:46 ET	600	33.775
03:48 ET	3200	33.725
03:50 ET	820	33.72
03:51 ET	9686	33.78
03:53 ET	1444	33.85
03:55 ET	6920	33.9301
03:57 ET	20548	34.095
04:00 ET	174044	34.07

Data delayed at least 15 minutes.

Yesterday
- HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES, from 8:05AM ET on Thursday Nov 21, 2024 by Dow Jones
  8:05AM ET on Thursday Nov 21, 2024 by Dow Jones
- ATTENTION Harmony Biosciences Holdings, Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights, from 7:25AM ET on Thursday Nov 21, 2024 by Dow Jones
  7:25AM ET on Thursday Nov 21, 2024 by Dow Jones
Nov 20, 2024
- Harmony Biosciences Holdings, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - HRMY, from 7:31AM ET on Wednesday Nov 20, 2024 by Dow Jones
  7:31AM ET on Wednesday Nov 20, 2024 by Dow Jones
Nov 19, 2024
- HRMY ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Harmony Biosciences Holdings, Inc. Shareholders Who Lost Money, from 7:30AM ET on Tuesday Nov 19, 2024 by Dow Jones
  7:30AM ET on Tuesday Nov 19, 2024 by Dow Jones
Nov 18, 2024
- HRMY ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Harmony Biosciences Holdings, Inc., from 7:26AM ET on Monday Nov 18, 2024 by Dow Jones
  7:26AM ET on Monday Nov 18, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesHRMY Harmony Biosciences Holdings Inc	1.9B	16.1x	---
United StatesAMPH Amphastar Pharmaceuticals Inc	2.2B	15.1x	---
United StatesCOLL Collegium Pharmaceutical Inc	980.7M	15.0x	---
United StatesANIP ANI Pharmaceuticals Inc	1.2B	-126.8x	-8.16%
United StatesPCRX Pacira Biosciences Inc	802.5M	-8.2x	---
United StatesTLRY Tilray Brands Inc	1.2B	-4.9x	---
As of 2024-11-22

Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company. It is focused on developing and commercializing therapies for patients living with rare neurological diseases as well as patients living with other neurological diseases who have unmet medical needs. Its product, WAKIX (pitolisant), is a first-in-class molecule with a novel mechanism of action designed to enhance histamine signaling in the brain by binding to H3 receptors. Its WAKIX is developed for the treatment of excessive daytime sleepiness (EDS) in adult patients with narcolepsy and treatment of cataplexy in adult patients with narcolepsy. It also provides HBS-102, an investigational compound, which is a melanin-concentrating hormone receptor 1 (MCHR1) antagonist that targets MCH neurons in the brain. It also develops ZYN002, a pharmaceutically manufactured synthetic cannabidiol. It is also focused on the rare epilepsy franchise in its expanding late-stage pipeline of CNS assets: EPX-100 and EPX-200.

Contact Information

Headquarters: 630 W Germantown Pike, Suite 215PLYMOUTH MEETING, PA, United States 19462
Phone: 484-539-9800
Fax: 302-655-5049

Executives

Non-Executive Chairman of the Board: Jeffrey Aronin
President, Chief Executive Officer, Director: Jeffrey Dayno
Chief Financial Officer, Chief Administrative Officer: Sandip Kapadia
Chief Scientific Officer: Kumar Budur
Chief Commercial Officer: Jeffrey Dierks

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$1.9B
Revenue (TTM)	$681.9M
Shares Outstanding	57.0M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	0.77
EPS	$2.11
Book Value	$8.23
P/E Ratio	16.1x
Price/Sales (TTM)	2.8
Price/Cash Flow (TTM)	12.9x
Operating Margin	25.71%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Harmony Biosciences Holdings Inc
NASDAQ:HRMYUnited States

Search Criteria

Charts

Recent News

Yesterday

HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES, from 8:05AM ET on Thursday Nov 21, 2024 by Dow Jones

ATTENTION Harmony Biosciences Holdings, Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights, from 7:25AM ET on Thursday Nov 21, 2024 by Dow Jones

Nov 20, 2024

Harmony Biosciences Holdings, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - HRMY, from 7:31AM ET on Wednesday Nov 20, 2024 by Dow Jones

Nov 19, 2024

HRMY ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Harmony Biosciences Holdings, Inc. Shareholders Who Lost Money, from 7:30AM ET on Tuesday Nov 19, 2024 by Dow Jones

Nov 18, 2024

HRMY ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Harmony Biosciences Holdings, Inc., from 7:26AM ET on Monday Nov 18, 2024 by Dow Jones

Pharmaceuticals - Diversified Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar